Theolytics in a £22.1M equity round with Taiho Ventures, Oxford Science Enterprises, M Ventures and Epidarex Capital

Biotech Health services Pharma

United Kingdom

United States

Netherlands

Japan

Investments

05 August 2023

Share:

Theolytics (company)

United Kingdom

Biotech Health services Pharma

Total investments received (USD): 59m

Round value (USD): 28.07m

Round investors: Epidarex Capital Merck Ventures Oxford Science Enterprises Taiho Ventures

Company: Theolytics

Industry: Biotech Health services Pharma

Related deals

Enterprise Therapeutics to raise £26M series B with Panakes Partners, Versant Ventures, Novartis Venture Fund, IP Group, Forbion Capital, Epidarex Capital

Health services Manufacturing Pharma

United Kingdom

United States

Netherlands

Switzerland

Italy

Investments 04 January 2024

Genomics plc to raise £35M from F-Prime Capital, Foresite Capital, MassMutual and Infinity Investment Partners

AI (big data) Biotech Health services Software Services

United Kingdom

United States

Investments 30 December 2023

Beckley Psytech in a $50 million deal, 40 of which capital raise, with atai Life Sciences.

Health services Manufacturing Pharma

United Kingdom

Germany

Investments 30 December 2023

Apollo Therapeutics raised $33.5m in an extended Series C funding led by Patient Square Capital, joined by M&G and Rock Springs Capital.

Biotech Manufacturing Pharma

United Kingdom

United States

Investments 03 December 2023

ViaNautis to raise £20M series A with UCB Ventures, BGF Ventures, 4BIO Capital

Biotech Health services Manufacturing Pharma

United Kingdom

Belgium

Investments 10 November 2023